Know Cancer

or
forgot password

Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer


Phase 2
18 Years
80 Years
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer


Inclusion Criteria:



- High risk prostate cancer without evidence of bone metastasis.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Federal Government

Study ID:

CLIN-003-02F

NCT ID:

NCT00108290

Start Date:

April 2004

Completion Date:

March 2007

Related Keywords:

  • Prostate Cancer
  • Prostate cancer
  • chemotherapy
  • hormone therapy
  • surgery
  • PSA
  • Gleason score
  • Prostatic Neoplasms

Name

Location

VA Maryland Health Care SystemBaltimore, Maryland  21201